Senior Medical Director, Medical Affairs
Full-timeSeniorGene Therapy
$296K - $362K/yr(estimated)
Description
<div><div><p style="text-align:left"><b><span>Why Join Intellia? </span></b></p></div><div><p style="text-align:left"><span><span>Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.</span></span><span> </span></p><p style="text-align:inherit"></p></div><div><p style="text-align:left"><span><span>Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.</span></span><span> </span></p><p style="text-align:inherit"></p></div><div><p style="text-align:left"><span><span>We want<span> </span></span><span>all of</span><span><span> </span>our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do <span class="WLU2">together. </span></span></span><span> </span></p><p style="text-align:inherit"></p><p style="text-align:inherit"></p></div></div><div><div><p><span><span>As t</span><span>he Medical Affairs</span><span><span> </span>Senior</span><span><span> </span>Medical Director for</span><span><span> </span></span><span>the NTLA-2001 ATTR</span><span><span> </span></span><span>amyloid<span> </span></span><span>p</span><span>olyneuropathy program,<span> </span></span><span>you embrace the challenge to create an innovative US and global Medical Affairs approach to support Intellia’s CRISPR/cas9 programs. This individual has a<span> </span></span><span>history of clinical and pharmaceutical industry experience, ideally in the fields of<span> </span></span><span>neuropathic</span><span><span> </span>disorders</span><span>, with a specialty in neurology<span> </span></span><span>being<span> </span></span><span>preferred</span><span>. The candidate will also have<span> </span></span><span>strong<span> </span></span><span>experience in product launches, including proven ability to translate and appropriately align commercial and medical goals and<span> </span></span><span>objectives</span><span>. This role</span><span><span> </span>will<span> </span></span><span>be</span><span><span> </span>responsible for</span><span><span> </span>developing and leading medical affairs plans in close collaboration with cross-functional teams, contributing to clinical strategy, collaborating to develop impactful medical education, evidence generation and healthcare system and key<span> </span></span><span>stakeholders</span><span><span> </span>engagement plans. In addition, the<span> </span></span><span>Senior<span> </span></span><span>Medical Director for</span><span><span> </span></span><span>the NTLA-2001 ATTR</span><span><span> </span></span><span>amyloid<span> </span></span><span>p</span><span>olyneuropathy program</span><span><span> </span></span><span>will be accountable for operational oversight of execution of the plans</span><span>.</span><span> </span></span></p><p><span> </span></p></div></div><div><div><p><b><span>Duties/Responsibilities</span></b><span> </span></p></div></div><div><div><ul><li><p><span><span>Medical Affairs Product Lead for NTLA-2001 ATTR-PN,<span> </span></span><span>our lead investigational therapy for the treatment of transthyretin amyloidosis in patients with polyneuropathy</span><span>,<span> </span></span><span>in the<span> </span></span><span>development of short-term and long-term strategy, as well as execution of the program medical affairs plan as a key component of the integrated brand plan and in full support of the key strategic imperatives</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Lead</span><span><span> </span>the<span> </span></span><span>Medical Access Commercial<span> </span></span><span>subteam</span><span><span> </span>for NTLA-200</span><span>1</span><span><span> </span>ATTR-PN</span><span>, together and in close partnership with the<span> </span></span><span>Medical Affairs Lead and<span> </span></span><span>Program Brand Lead</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Responsible</span><span><span> </span>for the alignment of all global medical affairs activities in close partnership with other members of the<span> </span></span><span>Medical Access Commercial<span> </span></span><span>subteam</span><span><span> </span></span><span>and Program Leadership Team</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Responsible<span> </span></span><span>for the medical accuracy and fair balance of medical information in educational and other medical communication and learning materials for both internal and external use.</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Collaborate with other line functions (Clinical Development, HEOR, etc.) to ensure that the medical evidence generation plan is aligned with the NTLA-200</span><span>1</span><span><span> </span>ATTR-PN</span><span><span> </span>program objectives </span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Develop and drive strategic engagement plan</span><span><span> </span>with stakeholders identified as strategic partners, including advocacy groups, medical societies, payers, and provider groups as well as medical experts in ATTR amyloid polyneuropathy</span><span>, especially in the United States </span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Work closely with Patient Advocacy, Medical Engagement and Regional Scientific<span> </span></span><span>Directors</span><span><span> </span>to develop and execute medical engagement strategy</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Plan</span><span><span> </span></span><span>and<span> </span></span><span>execute on holding<span> </span></span><span>of<span> </span></span><span>national and regional medical advisory boards</span><span><span> </span>with the ATTR-PN community </span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Provide medical input into the safety profile of the product in collaboration with Clinical Development and Patient Safety (PS) colleagues</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Collaborate with all Medical Affairs functions and work closely with Access & HEOR to support key educational, engagement and evidence generation initiatives</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Provide clinical support to the design and execution of HEOR studies, outcomes surveys, etc. in close collaboration with HEOR/Access colleagues</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Work closely with Clinical Development team to ensure<span> </span></span><span>optimal</span><span><span> </span>collaboration and inclusion of external clinicians/KOLs and other relevant healthcare system stakeholders in clinical trial planning, enrollment, and interpretation</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Develop relationships and drive interactions<span> </span></span><span>with investigators, KOLs, research institutions, and centers of excellence to oversee and support</span><span><span> </span>the ATTR-PN<span> </span></span><span>Medical Affairs</span><span><span> </span>plan </span><span> </span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Collaborate with the Scientific Communications team supporting the review and approval of publications and resources ensuring medical accuracy and alignment of all communication materials</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Lead Intellia Medical Affairs initiatives at key congress meetings and conferences</span><span>, including c</span><span>ontent development and presentation for internal and external medical education programs as needed</span></span><span> </span></p></li></ul></div><div><p><span> </span></p></div></div><div><div><p><b><span>Supervisory Responsibilities</span></b><span> </span></p></div></div><div><div><p><span><span>☐</span></span><span><span><span> </span>N/A</span></span><span> </span></p></div><div><p><span> </span></p></div></div><div><div><p><b><span>Require</span><span>ments</span></b><span> </span></p></div></div><div><div><p><b><span>Skills/Abilities</span></b><span> </span></p></div></div><div><div><ul><li><p><span><span>Robust clinical research experience within the pharmaceutical/biotech industry</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Previous</span><span><span> </span>experience<span> </span></span><span>leading<span> </span></span><span>a medical affairs/clinical development team with responsibility for late-stage clinical studies across multiple regions</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Solid communication, strategic, interpersonal, and negotiating skills, with ability to proactively predict challenges and solve problems</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Ability to drive decision-making within a multi-disciplinary, multi-regional, matrix teams</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Diplomacy and positive influencing abilities</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Knowledge of both regional and global Regulatory requirements</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Track record</span><span><span> </span>of successful and emerging research in therapeutic areas relevant to Intellia’s development programs and pipeline</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Demonstrated ability to present complex issues to management and contribute to executive level presentations and discussions</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Experience leading and motivating cross-functional teams and vendors/consultants</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Excellent interpersonal skills with an ability to respond to multiple external and internal queries, managing and handling conflict constructively</span></span><span> </span></p></li></ul></div><div><ul><li><p><span><span>Success working in a fast paced, matrixed, growing organization, partnering with multiple internal & external stakeholders</span></span><span> </span></p></li></ul></div></div><div><div><p></p><p><b><span>Education / Certifications</span></b><span> </span></p></div></div><div><p>MD, PharmD, PhD, or other relevant advanced degree</p></div><div><div><p></p><p><b><span>Experience</span></b><span> </span></p></div></div><div><div><p><span><span>At least<span> </span></span><span>10</span><span><span> </span></span><span>years<span> </span></span></span><span><span>experience</span><span><span> </span>in</span><span><span> </span>Medical Affairs and Clinical Development in the biotechnology/pharmaceutical industry</span></span><span> </span></p></div><div><p><span><span>Experience in Medical Affairs leadership for products addressing rare diseases, with strong therapeutic area knowledge relevant to mechanism of action of NTLA-200</span><span>1</span><span>.</span></span><span> </span></p></div></div><div><div><p><b><span>Physical Requirements</span></b><span> </span></p></div></div><div><div><p><span><span>Ability to sit or stand for multiple hours at a computer</span></span><span> </span></p></div><div><p><span><span>Manual dexterity for keyboarding; may include repetitive movements</span></span><span> </span></p></div></div><p><b>#LI-Remote</b></p><p></p><p></p><p><i><b>EEOC Statement:</b> Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.</i></p><p></p><p></p><p>Applications are accepted on a rolling basis, and will continue to be accepted until the position is filled at which point the position will be taken down.</p><p></p><p></p>The base salary for this position is expected to range between $295,965.00 - $361,735.00 USD per year.<p>The salary offered is determined based on a range of factors including, but not limited to, relevant education and training, overall related experience, specialized, rare or in-demand skill sets, internal comparators and other business needs. Upon joining Intellia, your salary will be reviewed periodically and additional factors such as time in role and performance will be considered. Intellia may change the published salary range based on company and market factors.</p><p>Additional compensation includes a performance-based annual cash bonus, a new hire equity grant, and eligibility to be considered for annual equity awards the value of which are determined annually at the Company’s discretion.</p><p></p><p>For more information about Intellia’s benefits, please <a target="_blank" href="https://www.intelliatx.com/careers/join-us/"><span style="color:#0000ff"><u>click here</u></span></a>.</p>
Intellia Therapeutics
BIOTECHNOLOGY
Therapeutic gene editing (CRISPR)
LocationCAMBRIDGE, MA
Open Jobs63
Gene Therapy
View Company ProfilePipeline
Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002N/A
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001N/A
NTLA-2001Phase 1
Biological NTLA-3001Phase 1/2
REGV131Phase 1/2